Megha Dhamne

  • Citations Per Year
Learn More
BACKGROUND Therapeutic options for patients with anaplastic gliomas (AGs) are limited despite better insights into glioma biology. The authors previously reported improved outcome in patients with recurrent glioblastoma treated with thalidomide and irinotecan compared with historical controls. Here, results of the AG arm of the study are reported, using(More)
The term ‘‘osmotic demyelination syndrome’’ (ODS) encompasses central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM), which often results from rapid correction of an osmolar abnormality [1]. Currently, there is no established treatment for ODS, and supportive care is the mainstay of therapy. In recent times, few case reports have highlighted(More)
  • 1